Buy & Sell Novavax Inc (NVAX) – Novavax Inc Price Today
Aura AI Summary
Key Stats
- $1.48BMarket Cap
- HealthSector
- -31.19%3M Drawdown
- $981.38MEnterprise Value
- -Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 57 daysTypical Hold Time
Novavax Inc (NVAX) is currently valued at a market capitalization of $1.48B, with an enterprise value of $981.38M. Over the past 52 weeks, Novavax Inc has traded between a low of $6.22 and a high of $11.19, highlighting its annual price range. Over the past three months, Novavax Inc has recorded a drawdown of -31.19%, reflecting recent price volatility. On average, investors hold Novavax Inc for approximately 57 days, indicating typical investor behavior on the platform.
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Most Recent News
India's social commerce market to reach $114.42B in 2026, driven by creator-led shopping and WhatsApp buying.
India's social commerce market is projected to grow at a 10% annual rate, reaching $114.42 billion by 2026 and $164.7 billion by 2031. Growth is fueled by creator-led discovery, messaging-based buying via WhatsApp, and affordable models like Meesho. ...

ROCKWOOL CFO Kim Junge Andersen vested 6,511 restricted shares under 2023 incentive plan
Kim Junge Andersen, CFO of ROCKWOOL A/S, vested 6,511 restricted share units on May 22, 2026, as part of the company's 2023 long-term incentive scheme. The shares were granted without a purchase price and traded on Nasdaq Copenhagen. This transaction...

ROCKWOOL CFO Kim Junge Andersen receives 6,511 shares under long-term incentive plan.
Kim Junge Andersen, CFO and Executive Vice President of ROCKWOOL A/S, has received 6,511 B-shares as part of the company's long-term incentive scheme from 2023. The shares were granted at no cost and the transaction was reported on May 22, 2026, in a...
